Discovery of a neutralizing antibody to treat covid-19
THE NEEDA number of therapeutic options have been explored over the course of the COVID-19 pandemic, yet there is still no effective treatment for hospitalized
THE NEEDA number of therapeutic options have been explored over the course of the COVID-19 pandemic, yet there is still no effective treatment for hospitalized
In cooperation with Enthera, YUMAB generated Ent001, a stabilized IgG4, without the need for bioinformatic engineering to reach an affinity to TMEM in the lower
Terms and conditions 1. General Our offers, sales and deliveries are exclusively subject to the terms and conditions provided hereinafter. These conditions comprise integral parts
Newsroom Events Social wall Publications Events The Festival of Biologics Basel is Europe’s largest biologics event, covering the start-to-finish of the industry in antibody therapies,
Technologies Delivering humanized antibodies for safer drugs YUMAB is an expert in fully human antibody development that offers an optimized discovery process tailored to the
Contact Contact form Contact persons Meet us Helpdesk Job applications Newsletter Contact us YUMAB GMBH Science Campus Braunschweig-SüdInhoffenstr. 738124 BraunschweigGermany (+49) 531 481170 0 info@yumab.com
Disclaimer, Data Privacy Statement Controller of the data processing on this website in the sense of the General Data Protection Regulation (GDPR) is: YUMAB GmbHScience
legal notice Address: YUMAB GmbH Science Campus Braunschweig-Süd Inhoffenstr. 738124 Braunschweig – Germany Phone (+49) 531-481170-0 E-Mail: info@yumab.com Commercial Registry: Amtsgericht Braunschweig, HRB 203964 VAT-ID:
Partnering Why partner with us? From target to lead – our mission is to accelerate & de-risk your therapeutic antibody pipeline. YUMAB is your fast-track
Antibody Discovery Powerful discovery process by phage display We support your race towards novel and better immunotherapeutics with our ultra-fast YUMAB® technology platform that combines
